JOINT VENTURE AGREEMENT BETWEEN REVITALIST LLC 
AND GCM PARTNERS, LLC IS TERMINATED

Revitalist-Company-Update-Regarding-Financial-and-Share-Settlements

Share Post:

VANCOUVER, BC, May 29, 2024 – Revitalist Lifestyle and Wellness Ltd. (the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) announces that the joint venture agreement dated March 10, 2023, as amended (the “JV Agreement”), between Revitalist LLC (“Revitalist”), its Tennessee subsidiary, and GCM Partners, LLC (“GCM”) has been terminated by GCM. Under the JV Agreement, GCM provided management services (“MSO”) to Revitalist. Revitalist expects that it will be in a position to engage another MSO provider, if it should require such services.

About Revitalist Lifestyle and Wellness Ltd. Revitalist (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) is a mental health and wellness company focused on comprehensive care in the ketamine wellness space offering innovative, evidenced-based services. The Company, through its subsidiary Revitalist, operates physical locations and virtual offices across 35 states.

Founded and led by Kathryn Walker, an advanced provider in the psychedelic space, Revitalist is at the forefront of this emerging field. Visit www.Revitalist.com for more information.
Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements
This news release includes certain forward-looking statements and forward-looking information (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities legislation. The use of any of the words “expect”, “anticipate”, “continue”, “estimate”, “objective”, “may”, “will”, “project”, “should”, “believe”, “plans”, “intends” and similar expressions are intended to identify forward-looking information or statements. The forward-looking statements and information are based on certain key expectations and assumptions made by the Company. Although the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Company can give no assurance that they will prove to be correct. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Forward-looking information in this news release includes statements concerning the Company’s general business plans and the Company’s expectation that it will be able to retain another MSO provider, if required. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward-looking statements included in this news release are expressly qualified by this cautionary statement. The forward-looking statements and information contained in this news release are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable laws. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements are described in Company’s management’s discussion and analysis for the nine-month period ended September 30, 2022, dated November 29, 2022, which is available on the Company’s profile at www.sedarplus.ca.

PR Contact
Kristina Spionjak
[email protected]

Stay Connected

More Press Releases

Psychedelic Community Reacts To FDA Committee’s Critique Of Lykos’ MDMA Studies Guest Column | June 14, 2024 As told to Abby Proch, executive editor of